Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_00584 |
| Species: | Homo sapiens |
| Position : | chr3:189630000-189680000 |
| Year: | 2017 |
| Title: | BRD4 promotes p63 and GRHL3 expression downstream of FOXO in mammary epithelial cells |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | prostate cancer |
| PMID: | 27980063 |
| MONDO: | MONDO:0008315 |
| Tissue: | Prostate gland |
| Tissue Ontology ID: | UBERON:0002367 |
| Cell Source: | VCaP |
| CVCL ID: | CVCL_2235 |
| Cell Type: | prostate carcinoma cell |
| Cell Ontology ID: | CL:0000066 |
| Experiment Type: | Enhancer activity assay |
| High Throughput Method: | ChIP-seq |
| Low Throughput Method: | Luciferase Reporter Assay, RT-RT-qPCR, ChIP-RT-qPCR, Western blot |
| Target gene : | TP63 |
| TF name : | BRD4 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|